Cargando…

Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera

The emergence and rapid evolution of SARS-CoV-2 variants have posed a major challenge to the global efforts to control the COVID -19 pandemic. In this study, we investigated the potential of two SARS-CoV-2 variants, BA.2 and BA.5, to evade neutralization by a human monoclonal antibody targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viriyakitkosol, Ratchanont, Wanitchang, Asawin, Srisutthisamphan, Kanjana, Saenboonreung, Janya, Boonkrai, Chatikorn, Pisitkun, Trairak, Jongkaewwattana, Anan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427911/ https://www.ncbi.nlm.nih.gov/pubmed/37593745 http://dx.doi.org/10.3389/fimmu.2023.1219546

Ejemplares similares

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses
por: Srisutthisamphan, Kanjana, et al.
Publicado: (2022)

A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model
por: Koonpaew, Surapong, et al.
Publicado: (2021)

A Single V672F Substitution in the Spike Protein of Field-Isolated PEDV Promotes Cell–Cell Fusion and Replication in VeroE6 Cells
por: Wanitchang, Asawin, et al.
Publicado: (2019)

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus
por: Wanitchang, Asawin, et al.
Publicado: (2018)

SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages
por: Thaweerattanasinp, Theeradej, et al.
Publicado: (2023)

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities
por: Kaewborisuth, Challika, et al.
Publicado: (2020)

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion
por: Wongthida, Phonphimon, et al.
Publicado: (2016)

Interaction Between PEDV and Its Hosts: A Closer Look at the ORF3 Accessory Protein
por: Jantraphakorn, Yuparat, et al.
Publicado: (2021)

Development and characterization of mouse anti-canine PD-L1 monoclonal antibodies and their expression in canine tumors by immunohistochemistry in vitro
por: Sirivisoot, Sirintra, et al.
Publicado: (2023)

Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development
por: Phakham, Tanapati, et al.
Publicado: (2022)

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers
por: Imsuwansri, Thanarath, et al.
Publicado: (2023)

Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants
por: Boonkrai, Chatikorn, et al.
Publicado: (2023)

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice
por: Kaewborisuth, Challika, et al.
Publicado: (2022)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
por: Mahasirimongkol, Surakameth, et al.
Publicado: (2022)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

Development and validation of point‐of‐care testing of albuminuria for early screening of chronic kidney disease
por: Vutthikraivit, Nuntanuj, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera
por: Ha, Binh, et al.
Publicado: (2021)

Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
por: Tada, Takuya, et al.
Publicado: (2021)

Deficiency of STING Promotes Collagen-Specific Antibody Production and B Cell Survival in Collagen-Induced Arthritis
por: Tansakul, Mookmanee, et al.
Publicado: (2020)

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2023)

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021)

Integrated Design of Antibodies for Systems Biology Using Ab Designer
por: Pisitkun, Trairak, et al.
Publicado: (2014)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
por: Lusvarghi, Sabrina, et al.
Publicado: (2021)

Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
por: Ulinici, Mariana, et al.
Publicado: (2023)

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases
por: Guo, Jian-Ping, et al.
Publicado: (2004)

DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity
por: Sustmann, Claudio, et al.
Publicado: (2019)

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera
por: Almasaud, Abdulrahman, et al.
Publicado: (2019)

Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Hot nuclei in 475 MeV, 2 GeV proton and 2 GeV $^{3}$He induced reactions
por: Ledoux, X, et al.
Publicado: (1995)

Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
por: Zhou, Wenhao, et al.
Publicado: (2022)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

ODP475 Developing suppurative thyroiditis
por: Katwal, Dilasha, et al.
Publicado: (2022)

475 Financial Toxicity in Dementia Caregiving
por: Hart, Danielle M., et al.
Publicado: (2023)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
por: Richardson, Simone I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1snh2rgh4bkvpgv7srdsbkibpa